Government ❯ Regulatory Agencies ❯ FDA

Health Policy

Public Health Discussions Women's Health Guidelines Women's Health Initiatives Deregulation Public Health Initiatives Advertising Regulations Compassionate Use Programs

FDA Eases Oversight of Wearables and Clinical Decision Support in Final Guidance

The shift prioritizes innovation by removing device oversight when products avoid clinical-grade claims.

FDA Panel Urges Looser Testosterone Rules, Including Descheduling and Broader Use